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ABSTRACT
Design of the study: Cross-sectional. Objectives: To evaluate the efficacy of minisling (Ophyra ™) in
women with stress urinary incontinence (SUI). Methods: A prospective, observational study comprised 13
patients who underwent minisling surgery from 2010 to 2011. It was analyzed the following variables: age,
subjective success rate (cure and/or improvement), immediate and late surgical complications. Quality of
life (QoL) parameters (King’s Health Questionnaire - KHQ) were analyzed before and after one year of
surgery. Results: Thirteen per cent (3/13) of women had their SUI relapsed, with 87.5% of subjective
success after one year of follow-up. After 12 months of follow-up, women who were considered subjec-
tively cured had improvement in all domains of KHQ QoL scores, except for personal relationships and
sleep/energy domains. Four patients had irritative symptoms after surgery and two patients evolved with
chronic urinary retention. Conclusion: Minisling Ophira was effective to improve SUI and to promote
better QoL on women with SUI. A larger sampling is needed to further compare these patients with women
who underwent to classic retropubic techniques.
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Introduction
The surgical treatment of stress urinary incon-
tinence (SUI) has been evolving to a minimal, less
traumatic invasivity. Synthetic grafts have been re-
placing traditional procedures, such as Burch colpo-
suspension or autologous slings, and efficacy has been
maintained. More than one hundred surgeries were
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created and we do not have an ideal condition to cor-
rect this disease, prevalent in 30%-50% of women
older than 60 years.1
  Synthethic retropubic slings were performed
by Petros and Ulmsten2, initiating the placement of
free tension vaginal tapes; a second-generation mid-
urethral sling (MUS) group was developed, with tran-
sobturator out-in approach described by Delorme in
20013 and DeLeval performed it in a opposite way
(in-out)4, reducing intraoperative complications and
causing similar objective and subjective cure rates.
However, they are still seen, p.ex. bladder and/or ure-
thral injuries, vascular hemorrhage.
Single-incision mini slings (SIMS) are the third
generation MUS group and were created with the con-
cept of using a shorter sling, avoiding the risk of mus-
cle perforations and minimizing the intra-operative
risks. There are at least four types of SIMS: TVT-
Secur ™ (Ethicon, Edinburgh, UK), MiniArc ™
(American Medical Systems, Minnetonka, MN, USA)
Ajust ™ (C.R. Bard, Murray Hill, NJ, USA) and
Ophira ™ (Promedon, Cordoba, Argentina).
TVT-Secur presents an absorbable material in
its distal shaft; MiniArc has a self-anchor shaft; Ajust
has one fixed and other adjustable anchors; Ophira
has two fixed anchors. Initially all SIMS was thought
to be as low efficacy; however, studies are showing
similar cure rates than synthetic MUS.
Experimentally, Ophira has shown the best fixa-
tion after seven days of surgery among other SIMS.5
Quality of life is another parameter of greater impor-
tance that should be included in post-operative as-
sessment. However, we do not have larger prospec-
tive trials published in medical literature about this
specific mini sling.  In this pilot study, we are aiming
to analyze the efficacy of a SIMS (Ophira™) inserted
in women with SUI after one year of treatment.
Methods
Participants and study design
A prospective, pilot study was carried out at
the “Hospital das Clínicas de Ribeirão Preto da USP”
with all female patients with SUI confirmed by
urodynamics with mild to moderate symptoms (uretral
hypermobility subtype). They were about to be sub-
mitted to surgical treatment and after signing informed
consent they filled out Kings Health Questionnaire
translated and validated to Portuguese language 6
about their urinary symptoms. Answers were classi-
fied according to Likert scale, where 0 was the ab-
sence of complaints and 100 the worst complaint at
the question.
All patients who refused surgery and did not
want to participate in this research were forwarded to
pelvic muscle treatment. It was excluded patients with
previous surgery for SUI, grade III obesity (BMI
higher 40 kg/m2), with uncontrolled comorbidities
(hypertension, diabetes), normal urodynamics, geni-
tal prolapse POP-Q equal or higher than grade 2.
Surgery
All patients were operated with regional
anesthesia. A vertical 3-cm incision was made, with a
1.5 cm distance from urethral meatus. A polipropilene
type 1 tape was positioned at a U distance, without
perforation of the obturatory membrane. Anterior vagi-
nal wall was closed with poliglecaprone 25 4.0 with
continuous suture. Women were assessed at immedi-
ate post-operative period, with 3, 6 and 12 months
after procedure. KHQ was applied after twelve months
of treatment. Subjective cure rate was defined as a
partial/total improvement after surgery when asked
the patients.
Statistics
Data was analyzed at SPSS statistical package
(Version 10.0 for Windows, SPSS, Chicago, IL, USA).
Data are presented as mean ± standard deviations and
percentages. About KHQ analysis, paired t-test was
utilized to assess if there was improvement of SUI
symptoms. A p value of 0.05 was considered as sta-
tistically significant.
Results
Thirteen patients were evaluated in this re-
search. Mean age was 52.75±12.02 years (range 32-
72), and half of them had obesity grade I. Most preva-
lent complaints were: stress urinary incontinence and
urgency incontinence. Irritative symptoms were found
in half of the patients. One quarter of women pre-
sented objective urine loss and a large percentage had
associated genital prolapse (Table 1).
When analyzing KHQ, it was found an im-
provement statistically significant on these women in
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Table 1: Urogynecological symptoms and physical findings before and after one year of surgery.
Variables N (%) - before N (%) - after
Stress urinary incontinence 13 (100%) 3 (12.5%)
Urgency incontinence 7 (53.8%) 3 (12.5%)
Urgency 6 (46.2%) 4 (30.8%)
Nocturia 6 (46.2%) 0
Increased daytime urinary frequence 5 (38.5%) 0
Nocturnal enuresis 4 (30.8%) Ignored
Incomplete bladder emptiness 4 (30.8%) Ignored
Urine insensible loss 4 (30.8%) Ignored
Coital incontinence 1 (7.7%) Ignored
Dysuria 1 (7.7%) Ignored
Necessity of effort maneuvers to end micturition 1 (7.7%) 0
Distal defect 8 (61.5%) Not applied
Anterior defect – all grade I 5 (38.5%) 35 (38.5%)
Apical defect 4 (30.8%) Not applied
Objective urine loss 3 (23.1%) 0
Table 2. – Preoperative and postoperative Kings Health Questionnaire (KHQ) data in 13 women
undergoing Ophira for SUI.
Domains of KHQ Mean before Mean after p value*
General health 56.25 21.88 0.052
Incontinence Impact 100.00 25.00 0.008
Role limitations 59.38 12.82 0.024
Physical limitations 55.63 10.62 0.042
Social limitations 44.37 41.75 NS
Personal relationships 51.76 49.80 NS
Emotions 60.23 51.80 NS
Sleep/energy 42.13 39.34 NS
Severity measures 48.20 29.11 0.058
* paired t-test
all domains, except in social limitations, personal
relationships and sleep/energy domains (Table 2).
After one year, women referred a subjective im-
provement of 87.5% in SUI, with three relapses after
this period. As complications, four patients had irri-
tative symptoms after surgery and two patients with
urinary chronic retention. None of the patients had
tape erosions.
Discussion
In this pilot study, we have verified that minis-
ling Ophira had improved life quality in patients with
SUI, with a great improvement in general score in
most of them and causing a better life quality. The
greatest impact was noticed in incontinence score,
with reinforces its importance as anti-incontinence
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device. Morbid obesity was an exclusion criteria be-
cause we still do not know if in this group of patients
a smaller graft would be a risk factor for relapsing
SUI. So, we preferred to include patients without this
physical characteristic.
Minislings are being compared with traditional
methods such as transobturator and retropubic slings.
A study comparing Miniarc with Monarc (transobtu-
rator sling) found no differences in the treatment of
patients with SUI.7 The same minisling had a pro-
spective, non-comparative study with 119 patients
followed after 12 months of surgery, and 80% were
cured and 11% showed improvement. A recent RCT
comparing Ajust (SIMS) with TVT-O (MUS) showed
similar patient-reported and objective cure rates
(85.5% versus 91.2%; 90% versus 97%, respectively),
with shorter stay and earlier return to normal activi-
ties and work for SIMS group.9 A long-term postop-
erative trial (5 years) comparing TOT sling and a tis-
sue-fixation system (TFS) showed a better efficacy
for TFS system (83% vs 75%) than TOT slings.10
All SIMS present differences regarding their
structure and anchoring systems, which makes the task
to compare them a difficult one. Furthermore, litera-
ture does not have enough research with this type of
synthetic material. The first RCT data on a minisling
was from a study from Basu et al. 11 when they com-
pared TVT with MiniArc and they have found that
SIMS had a lower efficacy rate; however, follow-up
was only of 6 months. However, newer researches
were presented 9,10, and showed a higher efficacy, but
we still do not know what is the best indication for
these tapes. A non-inferiority trial comparing minis-
ling with TVT on 263 patients showed similar sub-
jective cure rates in both groups with greater postop-
erative incontinence severity with the minisling than
the TVT.12 Another research with TVT-Secur in of-
fice with local anesthesia showed a success of 80%.13
Recently, an abstract published shown at IUGA
Congress about Ophira in a multicentre trial, showed
that from 124 patients who were operated, using the
pad test as an objective cure pattern, 85.3% of pa-
tients were dry14, with no cases of sexual dysfunc-
tion, severe bleeding, infection. Four patients had uri-
nary retention. They also evaluated quality of life with
ICIQ-SF and UDI-6, with improvement on SUI scores.
About postoperative complications, almost a
third of the group presented overactive bladder symp-
toms, which was seen in previous studies8,9,10; also, a
recent multicenter study showed 7.3% of de novo ur-
gency.14 We did not have any tape erosions, probably
due to small sampling.
This research showed that Ophira mini sling
had an efficacy rate in a short time, with similar effi-
cacy rates of traditional sling in SUI. It is not known
if relapse may occur in a longer period. One hypoth-
esis is that multipoint fixation arms provide stable
fixation of the sling for a long period. We hope to
increase the number of followed patients and see if
these results maintain.
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RESUMO
Desenho do estudo: Transversal. Objetivos: Avaliar a eficácia do minisling Ophyra ™ em mulheres com
incontinência urinária de esforço (IUE). Métodos: Estudo prospectivo, observacional, que abrangeu 13
pacientes que realizaram cirurgia de minisling entre 2010 e 2011. As seguintes variáveis foram analisa-
das: idade, taxa subjetiva de sucesso (cura e /ou melhora), complicações cirúrgicas imediatas e tardias.
Os parâmetros de qualidade de vida (King’s Health Questionnaire - KHQ) foram analisados antes e
depois de um ano de cirurgia. Resultados: Treze (3/13) por cento das mulheres recidivaram a IUE, com
87,5% de sucesso subjetivo depois de um ano de seguimento. Depois de 12 meses de seguimento, as
mulheres foram consideradas subjetivamente curadas em todos os domínios dos questionários de qua-
lidade de vida KHQ, exceto por relações pessoais e domínio de sono/energia. Quatro pacientes tiveram
sintomas irritativos depois da cirurgia e duas pacientes com retenção urinária crônica.
Conclusão: O minisling Ophira foi efetivo para melhorar a IUE e promover melhor qualidade de vida em
mulheres com IUE. Maior amostragem é necessária para posteriormente comparar essas pacientes com
mulheres que foram submetidas a técnicas retropúbicas clássicas.
Palavras-chave: Mini Sling; Incontinência Urinária de Esforço. Qualidade de Vida. Kings Health
Questionnaire.
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